Scientists have discovered a new immunotherapy strategy that reduces cancer recurrence in mouse experimental models. The study, published in Nature Communications, shows that a specific subtype of immune cell—type I dendritic cells—is especially effective at activating a strong immune response and generating immune memory against cancer.
Leave A Comment